Pacific Biosciences partners with Sage Science to co-market DNA size selection device
Ziopharm announces promising nonclinical and phase I study results of Ad-RTS-IL-12 in advanced melanoma
Arno Therapeutics to present positive new data supporting the potential of onapristone in endometrial and breast cancers at ASCO 2013
Submit an article to cafepharma's CP Wire. Click here to find out more.
| Company | Average | Last 24h |
Increase |
|---|---|---|---|
| Chugai | 1 | 6 | 500 % |
| Greenway Medical Technologies | 1 | 5 | 400 % |
| Neuralstem | 1 | 4 | 300 % |
| Delphi Medical Systems | 1 | 4 | 300 % |
| Advanced Bionics | 2 | 6 | 200 % |
| Circadian Technologies | 1 | 3 | 200 % |
| Aegerion | 1 | 3 | 200 % |
| Oncothyreon | 1 | 3 | 200 % |
| Cel-Sci | 2 | 6 | 200 % |
| ConforMIS | 3 | 8 | 167 % |